drugset / Trial / NCT02544191

GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia

NCT02544191

Phase 2 Unknown 30 enrolled Jinling Hospital, China
NaSingle-groupOpen-labelTreatment

Summary

Preliminary reports showed that hormonal treatment may improve the chance of retrieving viable testicular sperm from men with NOA. It was generally believed that gonadotrophin treatment would be ineffective in the presence of high plasma levels of endogenous gonadotrophin.The purpose of this study is to determine whether GnRHa(gonadotropin-releasing hormone agonist) combined with hCG(human chorionic gonadotropin) and hMG(human menopausal gonadotropin) are effective in the treatment of non-obstructive azoospermia.

Timeline

Start
2015-12
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Goserelin Other / unclassified 3.6 mg Subcutaneous
Subject human chorionic gonadotropin Protein / enzyme biologic 150 iu
Subject human chorionic gonadotropin Protein / enzyme biologic 2000 iu

Indications